Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02756403 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial of Three Antibiotic Regimens for First Trimester Abortions
A NA study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 181
- Enrollment target
NCT02756403 is a NA study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 181 participants.
The verdict
NCT02756403, a NA study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 181 participants
- Enrollment target
Study Summary
This study, a double blinded randomized controlled trial, is being done to compare side effects of commonly used antibiotic regimens prior to same day abortion procedures. In total, 180 pregnant women in their first trimester of pregnancy (5 0/6-13 6/7 weeks gestation) will be randomized to receive one of the three commonly used antibiotics (azithromycin, doxycycline, metronidazole) for same day abortion procedures or placebo prior to their abortion procedure. Approximately, 30-60 mins after study drug administration, the procedure will be performed. A sub-study will be completed on 40 women who consent to endometrial sampling and to have their blood drawn.
Interventions
- DRUG Placebo
- DRUG Azithromycin
- DRUG Metronidazole
- DRUG Doxycycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02756403
The ClinicalTrials.gov registry entry for NCT02756403 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02756403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02756403 about?
NCT02756403 is a clinical study titled "A Randomized Controlled Trial of Three Antibiotic Regimens for First Trimester Abortions". This study, a double blinded randomized controlled trial, is being done to compare side effects of commonly used antibiotic regimens prior to same day abortion procedures. In total, 180 pregnant women in their first trimester of pregnancy (5 0/6-13 6/7 weeks gestation) will be randomized to receive...
What is the current status of trial NCT02756403?
This trial is currently completed. It is a NA study. The enrollment target is 181 participants. The study started on 2016-03. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02756403?
The interventions under investigation include: Placebo (DRUG), Azithromycin (DRUG), Metronidazole (DRUG), Doxycycline (DRUG).
Who is sponsoring clinical trial NCT02756403?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.